Syncom Formul.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
14.04
-0.17 (-1.2%)
BSENSE

Jun 18

BSE+NSE Vol: 14.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Lincoln Pharma.
Ind-Swift Labs.
Amrutanjan Healt
Jagsonpal Pharma
Syncom Formul.
Bajaj Healthcare
Themis Medicare
Shukra Pharma.
Fermenta Biotec.
Accent Microcell
Why is Syncom Formulations (India) Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -63.92% and Operating profit at -50.69% over the last 5 years
2
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
3
With ROE of 16.6, it has a Fair valuation with a 3.6 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -18.63%, its profits have risen by 76.1% ; the PEG ratio of the company is 0.3
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.63% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Syncom Formul. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Syncom Formul.
-27.37%
-0.50
37.46%
Sensex
-5.06%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-64.25%
EBIT Growth (5y)
-50.07%
EBIT to Interest (avg)
31.65
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
9.88
Tax Ratio
24.42%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.22%
ROCE (avg)
80.28%
ROE (avg)
119.22%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
17
Industry P/E
34
Price to Book Value
3.22
EV to EBIT
17.27
EV to EBITDA
15.81
EV to Capital Employed
4.03
EV to Sales
2.50
PEG Ratio
0.32
Dividend Yield
NA
ROCE (Latest)
23.35%
ROE (Latest)
18.41%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
PBDIT(Q)

Highest at Rs 22.01 cr.

PAT(Q)

Highest at Rs 25.17 cr.

EPS(Q)

Highest at Rs 0.27

-1What is not working for the Company
NON-OPERATING INCOME(Q)

is 43.18 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Syncom Formul.
Profit After Tax (PAT) - Quarterly
At Rs 25.17 cr has Grown at 46.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 17.23 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 22.01 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 25.17 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.27
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Syncom Formul.
Non Operating Income - Quarterly
is 43.18 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Non Operating Income - Quarterly
Highest at Rs 14.55 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income